Management of Polymicrobial Candida and Bacterial Osteomyelitis

Infection Management

The Infectious Diseases Society of America recommends initiating fluconazole 400 mg daily for 6-12 months as the primary antifungal agent for Candida osteomyelitis, providing excellent bone and tissue penetration for susceptible Candida isolates 3, 1, 2
Consider echinocandin induction therapy for at least 2 weeks followed by fluconazole 400 mg daily for 6-12 months if the patient is critically ill or if fluconazole resistance is suspected, given the immunocompromised transplant status 1, 2
The 6-12 month duration of antifungal therapy is essential for cure and prevention of relapse in Candida bone infections 3, 1
Continue vancomycin and tobramycin systemically based on bacterial culture sensitivities and minimum inhibitory concentrations 4, 5
The antibiotic-impregnated nail provides only local antibiotic delivery and is insufficient as monotherapy for established osteomyelitis 4, 5
Duration of antibacterial therapy should be 4-6 weeks minimum for osteomyelitis 6

Perform urgent repeat surgical debridement of all residual necrotic and infected bone, as adequate source control is fundamental to successful treatment of deep Candida infections 4, 5, 1
Obtain fresh tissue and bone cultures from multiple sites to confirm all pathogens and assess for additional organisms 4, 5
Send specimens for both bacterial and fungal cultures with susceptibility testing 5, 1
Convert to external fixation immediately to provide fracture stability while allowing access for serial wound debridements and avoiding retained internal hardware in an infected field 4, 5

Plan for serial surgical debridements every 3-7 days until healthy granulation tissue is present and all necrotic tissue is removed 4, 5
Delay definitive skin closure until infection is controlled, typically after 2-4 weeks of systemic therapy with documented microbiological clearance 4, 1
Consider rotational flap or free tissue transfer once infection is eradicated, as primary closure over infected bone is contraindicated 4, 5
Maintain strict off-loading of the affected foot to prevent wound breakdown and promote healing 4, 5, 7

Repeat wound and bone cultures at 2 weeks to document microbiological clearance 1, 2
Monitor inflammatory markers (ESR, CRP) weekly initially 2
Assess clinical signs of improvement including reduction in wound erythema, drainage, pain, and systemic symptoms 1
Serial radiographs every 2-4 weeks to assess for progressive bone destruction or healing 5, 7
Continue antifungal therapy for the full 6-12 months even if clinical improvement occurs earlier 3, 1, 2
MRI at 3 months to assess extent of bone involvement and response to therapy 5, 7

Coordinate with transplant team regarding immunosuppression adjustment, as reduction may improve infection control but risks rejection 4
The immunocompromised state increases risk of treatment failure and may necessitate more aggressive surgical debridement 4, 5
Three critical reasons for treatment failure must be addressed: residual infected bone or hardware, inadequate antimicrobial coverage, and inadequate off-loading or vascular supply 4, 5, 7